Apelin and Atrial Fibrillation: The Role in the Arrhythmia Recurrence Prognosis.

2.50
Hdl Handle:
http://hdl.handle.net/10146/618211
Title:
Apelin and Atrial Fibrillation: The Role in the Arrhythmia Recurrence Prognosis.
Authors:
Salska, Agata; Dziuba, Michał; Salski, Witold; Chizynski, Krzysztof; Zielinska, Marzenna ( 0000-0002-0118-8610 )
Abstract:
Apelin is a novel peptide of wide expression and multiple biological functions including the crucial role in cardiovascular homeostasis. The apelin role in the pathophysiology of heart rhythm disorders is considered, although the reports are scarce so far. The purpose of this study is to investigate the potential utility of apelin as a marker of arrhythmia recurrence after direct-current cardioversion (DC). The prospective, observational study included 60 patients (aged 41-86; 30% female) with nonvalvular, persistent atrial fibrillation from the group of 204 consecutive patients scheduled for DC during the 12-month period (from May 2010 to May 2011) in the Cardiology Clinic Medical University of Lodz, Poland. The study group was divided into SCD (successful DC), 45 (75%) patients, and NDC (nonsuccessful DC), 15 (25%) patients. Within the SCD group, the subgroups were distinguished depending on the time sinus rhythm maintenance after DC: up to 7 days (SDC-7), 11 patients; 7 to 30 days (SDC-30), 12 patients; over 90 days (SDC-90), 22 patients. Patients were evaluated during the hospitalization and within the 3-month follow-up period. The apelin level was determined within the plasma samples collected at the admission, using the commercially available enzyme-linked immunosorbent assay (ELISA) Kit for apelin-36. It was found that the median value of initial apelin in the subset of patients from groups NDC + SDC-7 + SDC-30 is significantly higher than from group SDC-90 (p = 0.0463); there was no relationship between NDC and SCD overall. Neither of the compared subgroup pairs revealed statistically significant correlation between the proBNP concentration and the DC effectiveness in our population. In conclusion, in our study, proBNP was not a marker of arrhythmia recurrence whereas higher apelin concentration at the admission indicated patients in whom DC was not effective or they had an arrhythmia recurrence within a month-period observation.
Affiliation:
Nofer Institute of Occupational Medicine, Lodz, Poland
Citation:
Dis. Markers A2018, 2018:5285392
Journal:
Disease Markers
Issue Date:
2018
URI:
http://hdl.handle.net/10146/618211
DOI:
10.1155/2018/5285392
PubMed ID:
29721104
Additional Links:
https://www.hindawi.com/journals/dm/2018/5285392/
Type:
Article
Language:
en
ISSN:
1875-8630
Appears in Collections:
Articles

Full metadata record

DC FieldValue Language
dc.contributor.authorSalska, Agataen
dc.contributor.authorDziuba, Michałen
dc.contributor.authorSalski, Witolden
dc.contributor.authorChizynski, Krzysztofen
dc.contributor.authorZielinska, Marzennaen
dc.date.accessioned2018-06-04T10:12:38Z-
dc.date.available2018-06-04T10:12:38Z-
dc.date.issued2018-
dc.identifier.citationDis. Markers A2018, 2018:5285392en
dc.identifier.issn1875-8630-
dc.identifier.pmid29721104-
dc.identifier.doi10.1155/2018/5285392-
dc.identifier.urihttp://hdl.handle.net/10146/618211-
dc.description.abstractApelin is a novel peptide of wide expression and multiple biological functions including the crucial role in cardiovascular homeostasis. The apelin role in the pathophysiology of heart rhythm disorders is considered, although the reports are scarce so far. The purpose of this study is to investigate the potential utility of apelin as a marker of arrhythmia recurrence after direct-current cardioversion (DC). The prospective, observational study included 60 patients (aged 41-86; 30% female) with nonvalvular, persistent atrial fibrillation from the group of 204 consecutive patients scheduled for DC during the 12-month period (from May 2010 to May 2011) in the Cardiology Clinic Medical University of Lodz, Poland. The study group was divided into SCD (successful DC), 45 (75%) patients, and NDC (nonsuccessful DC), 15 (25%) patients. Within the SCD group, the subgroups were distinguished depending on the time sinus rhythm maintenance after DC: up to 7 days (SDC-7), 11 patients; 7 to 30 days (SDC-30), 12 patients; over 90 days (SDC-90), 22 patients. Patients were evaluated during the hospitalization and within the 3-month follow-up period. The apelin level was determined within the plasma samples collected at the admission, using the commercially available enzyme-linked immunosorbent assay (ELISA) Kit for apelin-36. It was found that the median value of initial apelin in the subset of patients from groups NDC + SDC-7 + SDC-30 is significantly higher than from group SDC-90 (p = 0.0463); there was no relationship between NDC and SCD overall. Neither of the compared subgroup pairs revealed statistically significant correlation between the proBNP concentration and the DC effectiveness in our population. In conclusion, in our study, proBNP was not a marker of arrhythmia recurrence whereas higher apelin concentration at the admission indicated patients in whom DC was not effective or they had an arrhythmia recurrence within a month-period observation.en
dc.language.isoenen
dc.relation.urlhttps://www.hindawi.com/journals/dm/2018/5285392/en
dc.rightsArchived with thanks to Disease markersen
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectapelinen
dc.subjectatrial fibrillationen
dc.subjectarrhythmiaen
dc.titleApelin and Atrial Fibrillation: The Role in the Arrhythmia Recurrence Prognosis.en
dc.typeArticleen
dc.contributor.departmentNofer Institute of Occupational Medicine, Lodz, Polanden
dc.identifier.journalDisease Markersen

Related articles on PubMed

This item is licensed under a Creative Commons License
Creative Commons
All Items in ECNIS-NIOM are protected by copyright, with all rights reserved, unless otherwise indicated.